Asymmetric Synthesis of KRAS G12C Inhibitor MK-1084 via a Crystallization-Induced Diastereomer Transformation (CIDT)

MK-1084 is a potent KRAS G12 inhibitor characterized by a complex macrocyclic ring system incorporating two atropisomeric axes from a restricted rotation around both <i>C-C</i> and <i>N-C</i> bonds. Herein, we report an efficient synthetic approach to manufacture MK-1084 to enable clinical trials. By leveraging the in-depth understanding of the inherent properties of axial chirality, we discovered and developed a one-pot crystallization-induced diastereomer transformation (CIDT)/carbonylation process to establish the unique and challenging macrocyclic core with double axial chiral centers from a racemic advanced precursor and readily available raw materials.

Authors

Institutions

Publication Details

Journal
Organic Letters
Published
2026-01-13
DOI
https://doi.org/10.1021/acs.orglett.5c04646
Primary Topic
Axial and Atropisomeric Chirality Synthesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Asymmetric Synthesis of KRAS G12C Inhibitor MK-1084 via a Crystallization-Induced Diastereomer Transformation (CIDT)

Kevin M. Belyk, Christopher C. Nawrat, Xin Wen, Kai‐Jiong Xiao et al.
Organic Letters
Axial and Atropisomeric Chirality Synthesis
article

Asymmetric Synthesis of KRAS G12C Inhibitor MK-1084 via a Crystallization-Induced Diastereomer Transformation (CIDT)

Kevin M. Belyk, Christopher C. Nawrat, Xin Wen, Kai‐Jiong Xiao, Gao Shang, Eugene E. Kwan, Zhiyan Song, Zhiguo J. Song, Matthew L. Maddess, Xu Jj, Heather C. Johnson, Aaron C. Sather, Jonathan M. E. Hughes, Hongming Li, Lushi Tan, Jin Zhang, Yongpeng Yuan, B. Wan, Jingjun Yin, Chao Fan, Jongrock Kong, Yu-hong Lam, Yonggang Chen, Guiquan Liu
article en

Abstract

MK-1084 is a potent KRAS G12 inhibitor characterized by a complex macrocyclic ring system incorporating two atropisomeric axes from a restricted rotation around both <i>C-C</i> and <i>N-C</i> bonds. Herein, we report an efficient synthetic approach to manufacture MK-1084 to enable clinical trials. By leveraging the in-depth understanding of the inherent properties of axial chirality, we discovered and developed a one-pot crystallization-induced diastereomer transformation (CIDT)/carbonylation process to establish the unique and challenging macrocyclic core with double axial chiral centers from a racemic advanced precursor and readily available raw materials.

Organic LettersVol. 28(3)
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Pharmaron (United Kingdom) (GB), Shanghai Institute of Pharmaceutical Industry (CN)
Openalex Percentile: Top 90%
Axial and Atropisomeric Chirality Synthesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.